Literature DB >> 23992603

The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.

William R Hiatt1, Sanjay Kaul, Robert J Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23992603     DOI： 10.1056/NEJMp1309610

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  65 in total

Review 1.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

2.  Targeting hyperglycaemia with anti-obesity drugs: time for a paradigm shift?

Authors:  Andrew J Krentz; Marcus Hompesch
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

Review 3.  Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA.

Authors:  Dorrin Zarrin Khat; Mansoor Husain
Journal:  Curr Diab Rep       Date:  2018-06-09       Impact factor: 4.810

Review 4.  Systematic reviews to ascertain the safety of diabetes medications.

Authors:  Michael R Gionfriddo; Oscar L Morey-Vargas; Juan P Brito; Aaron L Leppin; M Hassan Murad; Victor M Montori
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

Review 5.  A Plethora of GLP-1 Agonists: Decisions About What to Use and When.

Authors:  Susan L Samson; Alan J Garber
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

Review 6.  Cardiovascular effects of incretin therapy in diabetes care.

Authors:  Jongoh Kim; Susan L Samson
Journal:  Metab Syndr Relat Disord       Date:  2014-05-19       Impact factor: 1.894

Review 7.  Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors.

Authors:  Gerald H Tomkin
Journal:  World J Diabetes       Date:  2014-10-15

Review 8.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 9.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213

10.  Comparing diabetes medications: where do we set the bar?

Authors:  Kasia J Lipska; Harlan M Krumholz
Journal:  JAMA Intern Med       Date:  2014-03       Impact factor: 21.873
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.